We are live on ! Find out more
WST icon

West Pharmaceutical
WST

406 hedge funds and large institutions have $9.57B invested in West Pharmaceutical in 2019 Q3 according to their latest regulatory filings, with 64 funds opening new positions, 143 increasing their positions, 134 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

150% more funds holding in top 10

Funds holding in top 10: 2 → 5 (+3)

100% more first-time investments, than exits

New positions opened: 64 | Existing positions closed: 32

12% more capital invested

Capital invested by funds: $8.52B → $9.57B (+$1.05B)

9% more funds holding

Funds holding: 374 → 406 (+32)

7% more repeat investments, than reductions

Existing positions increased: 143 | Existing positions reduced: 134

0.89% less ownership

Funds ownership: 92.4% → 91.52% (-0.89%)

85% less call options, than puts

Call options by funds: $7.21M | Put options by funds: $47.8M

Holders
406
Holders Change
+32
Holders Change %
+8.56%
% of All Funds
8.9%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.11%
New
64
Increased
143
Reduced
134
Closed
32
Calls
$7.21M
Puts
$47.8M
Net Calls
-$40.5M
Net Calls Change
+$3.68M

Top Buyers

1
Millennium Management
Millennium Management
New York
+$71.8M
2
Brown Advisory
Brown Advisory
Maryland
+$26.3M
3
Morgan Stanley
Morgan Stanley
New York
+$25.4M
4
BlackRock
BlackRock
New York
+$24.6M
5
N
Nuveen
North Carolina
+$24.4M

Top Sellers

1
AllianceBernstein
AllianceBernstein
Tennessee
-$118M
2
UIM
USS Investment Management
United Kingdom
-$76.2M
3
EAM
Eagle Asset Management
Florida
-$39.7M
4
CTA
Carillon Tower Advisers
Florida
-$29.5M
5
Federated Hermes
Federated Hermes
Pennsylvania
-$22.3M
Name Holding Trade Value Shares
Change 		Change in
Stake
T. Rowe Price Associates
1
T. Rowe Price Associates
Maryland
$1.24B -$21.3M -154,807 -2%
BlackRock
2
BlackRock
New York
$1.05B +$24.6M +178,553 +2%
Vanguard Group
3
Vanguard Group
Pennsylvania
$1.05B +$10.1M +73,039 +1%
Franklin Resources
4
Franklin Resources
California
$635M -$4.91M -35,687 -0.8%
Neuberger Berman Group
5
Neuberger Berman Group
New York
$334M -$17.5M -127,129 -5%
State Street
6
State Street
Massachusetts
$306M -$14.3M -103,991 -5%
BAMCO Inc
7
BAMCO Inc
New York
$223M -$2.07M -15,067 -0.9%
JP Morgan Chase
8
JP Morgan Chase
New York
$216M -$4.2M -30,527 -2%
Capital Research Global Investors
9
Capital Research Global Investors
California
$204M +$10.9K +79 +0%
WCM Investment Management
10
WCM Investment Management
California
$192M +$8.44M +61,308 +5%
Artisan Partners
11
Artisan Partners
Wisconsin
$152M -$1.32M -9,560 -0.9%
Goldman Sachs
12
Goldman Sachs
New York
$141M +$8.73M +63,410 +7%
Janus Henderson Group
13
Janus Henderson Group
United Kingdom
$136M +$5.68M +41,266 +5%
Massachusetts Financial Services
14
Massachusetts Financial Services
Massachusetts
$133M -$4.17M -30,310 -3%
Fisher Asset Management
15
Fisher Asset Management
Washington
$127M -$1.39M -10,068 -1%
Geode Capital Management
16
Geode Capital Management
Massachusetts
$118M +$2.63M +19,128 +2%
Bank of New York Mellon
17
Bank of New York Mellon
New York
$116M -$1.29M -9,365 -1%
Norges Bank
18
Norges Bank
Norway
$102M +$1M +7,284 +1%
Invesco
19
Invesco
Georgia
$100M +$15.1M +109,911 +18%
Millennium Management
20
Millennium Management
New York
$95.4M +$71.8M +521,158 +343%
AllianceBernstein
21
AllianceBernstein
Tennessee
$94.8M -$118M -859,468 -56%
Federated Hermes
22
Federated Hermes
Pennsylvania
$89.5M -$22.3M -162,186 -20%
Brown Advisory
23
Brown Advisory
Maryland
$89.2M +$26.3M +190,868 +44%
Bessemer Group
24
Bessemer Group
New Jersey
$89.2M -$20.7M -150,692 -19%
CIP
25
Champlain Investment Partners
Vermont
$87.4M +$1.9M +13,770 +2%
1
2 3 4 5

WST Hedge Fund Activity: Q3 2019 in Review

406 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q3 2019, worth a combined $9.57B — up 12% from $8.52B a quarter earlier.

Buyers outnumbered sellers: 64 funds opened new WST positions and 32 closed out — a net gain of 32 holders — while 143 added to existing stakes and 134 trimmed.

The largest buyer was Millennium Management, adding an estimated $71.8M. The largest seller was AllianceBernstein, cutting an estimated $118M.

  • 406 institutional investors held West Pharmaceutical (WST) as of Q3 2019, up from 374 in Q2 2019.
  • Funds reported $9.57B of West Pharmaceutical stock for Q3 2019, up 12% quarter-over-quarter.
  • 64 funds opened new West Pharmaceutical positions in Q3 2019 and 32 closed out, a net change of +32 holders.
  • The largest West Pharmaceutical buyer in Q3 2019 was Millennium Management, an estimated $71.8M added.
  • The largest West Pharmaceutical seller in Q3 2019 was AllianceBernstein, an estimated $118M sold.

Based on aggregated 13F filings for Q3 2019.